title: [Interpretation of aspirin plasma concentration in the acute phase of Kawasaki disease].
authors.affiliation: Service de pharmacie, Centre Hospitalier Robert Ballanger, Aulnay-sous-Bois, France. patrick.hindlet@cep.u-psud.fr
authors.forename: Patrick
authors.initials: P
authors.lastname: Hindlet
authors.forename: Jennifer
authors.initials: J
authors.lastname: Le Grand
authors.forename: Véronique
authors.initials: V
authors.lastname: Duperrin
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Colin-Gorski
authors.forename: Alexandra
authors.initials: A
authors.lastname: Fabreguettes
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D001241:Aspirin / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000652:urine; D002675:Child, Preschool; D006801:Humans; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin